Man Group
LEGN icon

Man Group’s Legend Biotech LEGN Stock Holding History

Man Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,604
Closed -$445K – 2484
2026
Q1 		$445K Sell
24,604
-37,100
-60% -$707K ﹤0.01% 2121
2025
Q4 		$1.34M Buy
61,704
+27,900
+83% +$799K ﹤0.01% 1595
2025
Q3 		$1.1M Buy
33,804
+18,604
+122% +$687K ﹤0.01% 1634
2025
Q2 		$539K Buy
+15,200
New +$493K ﹤0.01% 1807
2023
Q1 		– Sell
-17,449
Closed -$871K – 2173
2022
Q4 		$871K Sell
17,449
-5,478
-24% -$265K ﹤0.01% 1353
2022
Q3 		$935K Buy
+22,927
New +$1.08M ﹤0.01% 1309
2022
Q2 		– Sell
-9,627
Closed -$407K – 1546
2022
Q1 		$350K Buy
+9,627
New +$380K ﹤0.01% 1699

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Man Group's LEGN Position: Q2 2026 in Review

Man Group sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 24,604 shares — an estimated $445K sold.

Man Group first reported a position in LEGN in Q1 2022 and held it in 7 quarters. The position peaked at $1.34M in Q4 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Man Group reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
  • Man Group sold 24,604 Legend Biotech shares in Q2 2026, an estimated $445K.
  • Man Group first reported a position in Legend Biotech in Q1 2022 and held it in 7 quarters.
  • Man Group's Legend Biotech position peaked at $1.34M in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.